PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

NCT03423264 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped unable to accrue

Conditions

Oropharyngeal Cancer
HPV-Related Squamous Cell Carcinoma

Interventions

DRUG: Gabapentin

Sponsor

University of Chicago